PRDX1在胃癌细胞上皮间充质转化中的作用及机制
该研究通过70例胃癌及癌旁正常黏膜组织免疫组化检测PRDX1蛋白表达,并分析其与临床病理特征的关系;同时在AGS细胞中用PRDX1-siRNA转染,检测细胞增殖、侵袭及EMT相关标志物表达。结果显示PRDX1在胃癌中高表达且与浸润深度和淋巴结转移相关,敲低PRDX1可抑制AGS细胞增殖、侵袭和迁移,并逆转EMT标志物表达。结论提示PRDX1可能通过调控EMT促进胃癌进展。
要点
- PRDX1在胃癌组织阳性率81.4%,高于癌旁正常黏膜27.1%。
- PRDX1表达与胃癌浸润深度和淋巴结转移相关。
- 敲低PRDX1抑制AGS细胞增殖、侵袭和迁移,并逆转EMT标志物。
核心结论
- PRDX1可能通过调控胃癌细胞的EMT促进胃癌进展。
研究设计与样本
- 取70例胃癌手术标本的癌及癌旁正常黏膜组织,用免疫组化检测PRDX1蛋白并分析其与临床病理特征的关系。
- 合成PRDX1-siRNA并转染人胃癌细胞株AGS,用MTT法检测细胞活性、Transwell小室实验检测侵袭能力。
- 用实时荧光定量PCR和Western blot检测PRDX1及E-cadherin、N-cadherin、vimentin、claudin-1的mRNA和蛋白表达。
主要发现
- 胃癌组织中PRDX1蛋白表达阳性率为81.4%,高于癌旁正常黏膜的27.1%(P<0.05)。
- PRDX1蛋白表达与胃癌的浸润深度、淋巴结转移有关(均P<0.05)。
- AGS细胞中PRDX1 mRNA和蛋白表达水平分别为2.216±0.445和1.212±0.136,均高于GES-1细胞的0.342±0.041和0.328±0.038(均P<0.05)。
- PRDX1-siRNA转染后AGS细胞活性明显降低(均P<0.05)。
- LV-PRDX1-siRNA组穿膜细胞数为(112.00±17.98)个、细胞迁移率为(50.87±9.79)%,低于阴性对照组的(192.50±22.02)个、(83.03±8.67)%和空白对照组的(193.83±22.40)个、(82.40±7.21)%(均P<0.05)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Objective: To explore the effect and mechanism of peroxiredoxin1 (PRDX1) in epithelial mesenchymal transformation (EMT) of gastric cancer cells. Methods: The expression of PRDX1 protein was detected by immunohistochemistry (IHC) in 70 paraffin specimens of cancer and normal mucosa adjacent to gastric cancer, and the relationship between PRDX1 protein and clinicopathological characteristics was analyzed. Then PRDX1-small interfering RNA (siRNA) was synthetized and transfected into human gastric cancer cell line AGS, and 3-(4, 5-dimethyl-2-thiazolyl)-2, 5-diphenyl-2H tetrazolium bromide (MTT) assay was used to test cell proliferation. Transwell chamber assay was employed to test invasion of cells. Real-time quantitative polymerase chain reaction (RT-qPCR) and western blot were utilized to test the expressions of PRDX1, E-cadherin, N-cadherin, vimentin, and claudin-1. Results: The positive rate of PRDX1 protein expression in gastric cancer was 81.4%, higher than that in normal mucosa (27.1%, P<0.05). The expression of PRDX1 protein was related to invasive depth and lymph node metastasis of gastric cancer (P<0.05). The expressions of PRDX1 mRNA and protein in AGS cells (2.216±0.445, 1.212±0.136), were higher than those in GES-1 cells (0.342±0.041, 0.328±0.038) (P<0.05). When PRDX1-siRNA was transfected into AGS cells, the proliferation of AGS cells was significantly inhibited (all P<0.05). The invasion and migration rate of AGS cells in the transfection group [(112.00±17.98), (50.87±9.79)%] were significantly lower than those of the negative control group [(192.50±22.02), (83.03±8.67)%] and blank control group [(193.83±22.40), (82.40±7.21)%] (all P<0.05). The expressions of mRNA and protein of N-cadherin, vimentin and claudin-1 decreased, while the expression of E-cadherin increased when PRDX1-siRNA was transfected into AGS cells (P<0.05). Conclusion: PRDX1 may promote the development of gastric cancer by regulating the EMT of gastric cancer cells. 目的: 探讨过氧化物酶1(PRDX1)在胃癌上皮间充质转化(EMT)过程中的作用机制。 方法: 取70例胃癌手术标本的癌及癌旁正常黏膜组织,应用免疫组化技术检测PRDX1蛋白的表达,并分析PRDX1蛋白表达与临床病理特征的关系。合成针对PRDX1基因的PRDX1-siRNA并转染人胃癌细胞株AGS,采用四甲基偶氮唑蓝(MTT)法检测细胞活性,Transwell小室实验检测细胞侵袭能力,实时荧光定量聚合酶链反应和Western blot法检测PRDX1和E-钙黏素(E-cadherin)、N-钙黏素(N-cadherin)、波形蛋白(vimentin)、紧密连接蛋白1(claudin-1)的mRNA和蛋白表达。 结果: 胃癌组织中PRDX1蛋白表达阳性率为81.4%,高于癌旁正常黏膜(27.1%,P<0.05)。PRDX1蛋白表达与胃癌的浸润深度、淋巴结转移有关(均P<0.05)。AGS细胞中PRDX1 mRNA和蛋白的表达水平分别为2.216±0.445和1.212±0.136,均高于正常胃上皮细胞株GES-1(分别为0.342±0.041和0.328±0.038,均P<0.05)。PRDX1-siRNA转染后,AGS细胞的细胞活性明显降低(均P<0.05),LV-PRDX1-siRNA组穿膜细胞数为(112.00±17.98)个,细胞迁移率为(50.87±9.79)%,低于阴性对照组[(192.50±22.02)个、(83.03±8.67)%,均P<0.05]和空白对照组[(193.83±22.40)个、(82.40±7.21)%,均P<0.05]。LV-PRDX1-siRNA组AGS细胞中N-cadherin、vimentin、claudin-1的mRNA和蛋白表达下降,而E-cadherin表达增高(均P<0.05)。 结论: PRDX1基因可能通过调控胃癌细胞的EMT促进了胃癌的进展。.
引用
- Tan BB, Li Y, Li SJ, et al. [Effect and mechanism of PRDX1 in epithelial mesenchymal transformationin of gastric cancer cells]. Zhonghua Zhong Liu Za Zhi. 2020. PMID: 33256302. doi:10.3760/cma.j.cn112152-20200225-00126
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。